Ten suspects were arrested on Saturday (March 15) in a sweeping operation conducted by the National Drug Authority (NDA) in Kampala, during which government drugs and tampered-with diagnostic kits ...

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that ...

Providing feedback following point-of-care urine testing for tenofovir concentrations was associated with increased PrEP ...

Lynae Darbes, PhD, presented research on the effectiveness of a home-based intervention for HIV prevention among couples ...

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.